Organization Announcements

::::::

 
 
Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.
 
 
Airfinity [to 29 Jan 2022]
https://www.airfinity.com/insights
INSIGHTS & COMPANY NEWS
No new digest content identified.
 
 
Paul G. Allen Frontiers Group [to 29 Jan 2022]
https://alleninstitute.org/news-press/
News
2021 Annual Report: unknown | known
Good science often raises just as many questions as it answers.
January 24, 2022
Whether it’s classifying the billions of neurons that make up our brain, tracing the lineages of our development or understanding the detailed ins and outs of our cells, Allen Institute scientists are making the unknown known — and ultimately helping us to understand what it means to be human.
 
 
BARDA – U.S. Department of HHS [to 29 Jan 2022]
https://aspr.hhs.gov/newsroom/Pages/NewsRoomHome.aspx
News
UPDATE — Allocation of Bamlanivimab/Etesevimab and REGEN-COV Therapeutics Paused
Monday, January 24, 2022
 
 
BMGF – Gates Foundation [to 29 Jan 2022]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
Bill & Melinda Gates Foundation Appoints Board of Trustees – Four New Members Join Co-Chairs Bill Gates and Melinda French Gates to Shape Foundation Governance and Increase Impact
In inaugural foundation annual letter, CEO Mark Suzman reflects on evolution of foundation’s governance and work to fight poverty, disease, and inequity globally
SEATTLE (January 26, 2022) — Today, the Bill & Melinda Gates Foundation appointed a board of trustees, with Strive Masiyiwa, Baroness Nemat (Minouche) Shafik, Thomas J. Tierney, and Gates Foundation CEO Mark Suzman joining co-chairs Bill Gates and Melinda French Gates as members. The board members will work alongside Gates and French Gates, bringing independent and diverse perspectives to help strengthen the foundation’s governance…
 
 
Bill & Melinda Gates Medical Research Institute [to 29 Jan 2022]
https://www.gatesmri.org/news
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X [to 29 Jan 2022]
https://carb-x.org/
News
No new digest content identified.
 
 
Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 29 Jan 2022]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: Informed Consent: A Monthly Review – January 2022 is now posted here
 
 
CEPI – Coalition for Epidemic Preparedness Innovations [to 29 Jan 2022]
http://cepi.net/
Latest News
CEPI partners with BioNet to expand variant-proof vaccine programme
OSLO, Norway, 25 January 2022: CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the latest award under its $200m programme, launched in March 2021, to advance the development of vaccines that provide broad protection against SARS-CoV-2 variants and other Betacoronaviruses.1 CEPI will partner with BioNet—a French-Thai vaccine manufacturer and member of the Developing Country Vaccine Manufacturing network (DCVMN)—providing up to $16.9 million to support preclinical studies, Phase I and Phase II clinical trials, production of necessary clinical trial material, and process and analytical development…
 
 
DARPA – Defense Advanced Research Projects Agency [U.S.] [to 29 Jan 2022
https://www.darpa.mil/news
News
No new digest content identified.
 
 
Duke Global Health Innovation Center [to 29 Jan 2022]
https://dukeghic.org/
Our Blog
No new digest content identified.
 
 
EDCTP [to 29 Jan 2022]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
News
No new digest content identified.
 
 
Emory Vaccine Center [to 29 Jan 2022]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.
 
 
European Vaccine Initiative [to 29 Jan 2022]
http://www.euvaccine.eu/
Latest News, Events
No new digest content identified.
 
 
Fondation Merieux [to 29 Jan 2022]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.
 
 
Gavi [to 29 Jan 2022]
https://www.gavi.org/
News Releases
No new digest content identified.

GHIT Fund [to 29 Jan 2022]
https://www.ghitfund.org/newsroom/press
No new digest content identified.
 
 
Global Fund [to 29 Jan 2022]
https://www.theglobalfund.org/en/news/
News & Stories
Global Fund Announces Shunsuke Mabuchi as New Head of Resilient and Sustainable Systems for Health
26 January 2022
Geneva – The Global Fund is pleased to announce that Shunsuke Mabuchi is joining the Global Fund as the new Head of Resilient and Sustainable Systems for Health, starting in March 2022.
A senior global health leader, Shun brings a unique combination of experience and leadership in health systems strengthening, pandemic preparedness, program delivery and emergency response. He joins the Global Fund at a critical time for the implementation of the new strategy, and will focus on maximizing people-centered, integrated systems for health to deliver impact, resilience and sustainability…
 
 
Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 29 Jan 2022]
https://www.glopid-r.org/news/
News
No new digest content identified.
 
 
Hilleman Laboratories [to 29 Jan 2022]
http://www.hillemanlabs.org/
News & Insights
No new digest content identified.
 
 
HHMI – Howard Hughes Medical Institute [to 29 Jan 2022]
https://www.hhmi.org/news
Press Room
No new digest content identified.
 
 
Human Vaccines Project [to 29 Jan 2022]
http://www.humanvaccinesproject.org/
News
Press Release
Jan 25, 2022
2021 Michelson Prizes Push New Frontiers in Human Immunology
 
 
IAVI [to 29 Jan 2022]
https://www.iavi.org/
Latest News
Website not responding at inquiry.

 
 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.
 
 
ICRC [to 29 Jan 2022]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
Hacking the data of the world’s most vulnerable is an outrage
ICRC’s Director-General Robert Mardini addresses the recent cyber-attack on humanitarian data which puts humanitarian protection and assistance at risk.
29-01-2022 | Article

Explosive weapons: Civilians in populated areas must be protected
Explosive Weapons with Wide Area Effects: A Deadly Choice in Populated Areas – Report provides recommendations to protect civilians
26-01-2022 | Report

 
 

Wars in cities: protection of civilians in urban settings
I commend Norway and the leadership of Prime Minister Støre, for bringing attention to this critical humanitarian concern.
25-01-2022 | Statement

 
 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.
 
 
IFRC [to 29 Jan 2022]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
27/01/2022
Syria: Extremely harsh winter raises acute humanitar…

25/01/2022
Tonga: Aid ramped up after eruption and tsunami

25/01/2022
Philippines: New data reveals Typhoon Rai wrecked 1…
 
 
Institut Pasteur [to 29 Jan 2022]
https://www.pasteur.fr/en/press-area
Press Documents
No new digest content identified.
 
 
IOM / International Organization for Migration [to 29 Jan 2022]
http://www.iom.int/press-room/press-releases
News – Selected
News
28 Jan 2022
Statement by the Director General António Vitorino on the Death of Demetrios G. Papademetriou

News
28 Jan 2022
IOM and UNOCT Sign Agreement to Collaborate on API/PNR Technical Assistance

News
25 Jan 2022
Intensifying Drought Threatens to Displace Over 1 Million People in Somalia
 
 
ISC / International Science Council [to 29 Jan 2022]
https://council.science/current/
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
News Blogs Podcasts
Launch of a new ISC regional presence in Latin America and the Caribbean
Ensuring regional resonance and global impact
28.01.2022
Following an open call for expressions of interest to host an International Science Council (ISC) regional presence in Latin America and the Caribbean, the ISC is delighted to announce that the Colombian Academy of Exact, Physical and Natural Sciences will host a Regional Focal Point for Latin America and the Caribbean (RFP-LAC), during the 2022 – 2024 term.
 
 
IVAC [to 29 Jan 2022]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
Webinar: Making COVID-19 vaccines APPEALing: Pilot message testing in India
Registration: https://bit.ly/3fYNdv0
When: February 17, 2022 from 12:00pm-1:00pm ET
 
 
IVI [to 29 Jan 2022]
http://www.ivi.int/
IVI News & Announcements
New studies: Vi-DT vaccine is safe and immunogenic, with booster dosing potentially eliciting long-term immune responses
January 27, 2022 – SEOUL, Republic of Korea – A new study shows that late booster dosing with Vi polysaccharide conjugated with diphtheria toxoid (Vi-DT), one of the typhoid conjugate vaccines (TCVs), at 27.5 months post-first dose is safe and elicits robust immune responses in children aged 6-23 months. The findings from this study newly published online in npj Vaccines support the use of TCV booster doses to confer long-term protection against typhoid fever in young children…

IVI and NVI partner for collaborative vaccine R&D and capacity building
January 20, 2022
 
 
Johns Hopkins Center for Health Security [to 29 Jan 2022]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.
 
 
MSF/Médecins Sans Frontières [to 29 Jan 2022]
http://www.msf.org/
Latest [Selected Announcements]
No new digest content identified.
 
 
National Academy of Medicine – USA [to 29 Jan 2022]
https://nam.edu/programs/
Selected News/Programs/Events
No new digest content identified.
 
 
National Academy of Sciences – USA [to 29 Jan 2022]
http://www.nasonline.org/news-and-multimedia/
News
National Academies Partner with Chan Zuckerberg Initiative on New Grant Program to Recognize and Further Leadership by Biomedical Researchers Who Promote Diversity Equity and Inclusion
January 25, 2022
The National Academies are partnering with the Chan Zuckerberg Initiative to administer a new funding opportunity that aims to recognize and further the leadership and scientific accomplishments of excellent biomedical researchers who – through outreach mentoring and teaching – have a record of promoting diversity equity and inclusion in their fields.

Safe Passage for Scientists – Evacuating Scientists and Engineers from Afghanistan
January 25, 2022
When the Taliban captured Kabul last year a group of scientists and engineers with ties to the National Academies were desperately seeking a way out of Afghanistan. During a recent webinar Vaughan Turekian recounted the effort to get these scientists and their families to safety.
 
 
National Vaccine Program Office – U.S. HHS [to 29 Jan 2022]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
National Vaccine Advisory Committee [NVAC] 2022 Meetings
February 10-11, 2022
 
 
NIH [to 29 Jan 2022]
http://www.nih.gov/news-events/news-releases
News Releases
Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19
January 27, 2022 — NIH trial compared hIVIG plus remdesivir to remdesivir alone.

Mix-and-match trial finds additional dose of COVID-19 vaccine safe, immunogenic
January 26, 2022 — NIH-sponsored study assessed dose in adults fully vaccinated with any EUA or approved COVID-19 vaccine

Social connectedness, sleep, and physical activity associated with better mental health among youth during the COVID-19 pandemic
January 24, 2022 — NIH-supported study also found girls were at higher risk for stress, anxiety, and depression than boys.
 
 
OECD [to 29 Jan 2022]
http://www.oecd.org/newsroom/publicationsdocuments/bydate/
Newsroom
No new digest content identified.
 
 
PATH [to 29 Jan 2022]
https://www.path.org/media-center/
Press Releases
No new digest content identified.
 
 
Sabin Vaccine Institute [to 29 Jan 2022]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.
 
 
UNAIDS [to 29 Jan 2022]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
28 January 2022
New report highlights vital role of community-led organizations in pandemic response and preparedness
In a new UNAIDS report, Holding the line: communities as first responders to COVID-19 and emerging health threats, organizations led by and for people living with HIV and key populations detail their efforts to respond to the colliding pandemics of COVID-19 and HIV. Drawing on qualitative survey data spanning 225 community-led organizations across 72 countries, the report provides a snapshot of the organizations’ work during early 2020 to sustain the HIV response while supporting their communities through the COVID-19 pandemic. The report also illuminates the high-priority actions that are still urgently needed to ensure the continuity of HIV-related services, as well as the sustainability of the community-led organizations providing them…

UNHCR Office of the United Nations High Commissioner for Refugees [to 29 Jan 2022]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
Jordan issues record number of work permits to Syrian refugees
Country is at forefront of global efforts to give both refugees and host communities access to decent work
25 January 2022
 
 
UNICEF [to 29 Jan 2022]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Statement
01/27/2022
No excuses. Keep schools open. Children can’t wait
Statement by UNICEF Executive Director Henrietta Fore

Press release
01/26/2022
Learning loss must be recovered to avoid long-term damage to children’s wellbeing and productivity, new report says
New recommendations from the Global Education Evidence Advisory Panel (GEEAP) offer guidance on how to recover learning and prevent further loss, including prioritizing the full reopening of schools

Press release
01/23/2022
COVID:19 Scale of education loss ‘nearly insurmountable’, warns UNICEF
Media factsheet

Unitaid [to 29 Jan 2022]
https://unitaid.org/
Featured News
No new digest content identified.
 
 
USAID [to 29 Jan 2022]
https://www.usaid.gov/news-information/press-releases/2021
Selected Press Releases, Statements, Announcements
News
New USAID Initiatives in Honduras
January 27, 2022
As part of USAID’s $48 million commitment to help Honduras fight COVID-19, USAID is providing an additional $500,000 under the American Rescue Plan Act to promote delivery of and widespread and equitable access to safe and effective COVID-19 vaccinations. Specifically, USAID will promote transparency and accountability in government COVID-19 efforts, strengthen vaccine information systems, increase data availability and use, and address issues of vaccine hesitancy and misinformation in vulnerable communities. These funds will help turn vaccines into vaccinations, including the 3.9 million doses already donated by the U.S. and several hundred thousand additional doses arriving in the next two months. USAID is also providing more than 500,000 pediatric syringes to enable the start of vaccinations for Honduran children.
 
 
Vaccine Equity Cooperative [nee Initiative] [to 29 Jan 2022]
https://vaccineequitycooperative.org/news/
News
No new digest content identified.
 
 
Vaccination Acceptance & Demand Initiative [Sabin) [to 29 Jan 2022]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.
 
 
Vaccine Confidence Project [to 29 Jan 2022]
http://www.vaccineconfidence.org/
News, Research and Reports
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia [to 29 Jan 2022]
http://www.chop.edu/centers-programs/vaccine-education-center
News
Vaccine Update Newsletter January 2022
 
 
Wellcome Trust [to 29 Jan 2022]
https://wellcome.ac.uk/news
News. Opinion, Reports
Explainer
Seven vital questions about RNA Covid-19 vaccines
27 January 2022

Opinion
Wellcome’s ambitions for 2022 and beyond
24 January 2022
Cheryl Moore, Director of Research Programmes, shares how Wellcome plans to spend £16 billion over the next ten years to advance scientific discovery and take on the world’s most pressing health issues.
 
 
The Wistar Institute [to 29 Jan 2022]
https://www.wistar.org/news/press-releases
Press Releases
Jan. 27, 2022
The Wistar Institute Hosts U.S. Department of Commerce Official Making Major Grant Announcements to Strengthen Workforce Pipelines in Philadelphia & Across the Nation
Wistar is a finalist of the STEM Talent Challenge to create a new life science workforce training program to address Pennsylvania industry growth and demand for skilled workers.

WFPHA: World Federation of Public Health Associations [to 29 Jan 2022]
https://www.wfpha.org/
Latest News – Blog
No new digest content identified.
 
 
World Bank [to 29 Jan 2022]
http://www.worldbank.org/en/news/all
Selected News, Announcements
Health and WASH Services Reaching Most Vulnerable Yemenis Despite Difficult Context
Synopsis Just over four years ago, as Yemenis struggled with the effects of armed conflict on their lives, the World Bank, UNICEF, and World Health Organization (WHO) joined forces with Yemen’s Ministry…
Date: January 27, 2022 Type: Brief

Prioritizing Learning During COVID-19: The Most Effective Ways to Keep Children Learning During and Post-Pandemic
Recommendations of the Global Education Evidence Advisory Panel The short- and long-term impact of the Covid-19 crisis on children’s education, wellbeing, and future productivity is profound. Almost two…
Date: January 26, 2022 Type: Publication

Learning Loss Must be Recovered to Avoid Long-term Damage to Children’s Wellbeing and Productivity, New Report Says
New recommendations from the Global Education Evidence Advisory Panel (GEEAP) offer guidance on how to recover learning and prevent further loss, including prioritizing the full reopening of schools FLORENCE/LONDON/NEW…
Date: January 26, 2022 Type: Press Release

World Bank-financed Moderna vaccines arrive in Nepal to protect children and youth from COVID-19
KATHMANDU, January 25, 2022 – 1.66 million of the four million doses of Moderna vaccines financed by the World Bank arrived in Nepal yesterday. The remaining doses will be delivered shortly. Nepal will deploy these vaccines for adolescents 12-17 years to safeguard them from the health impacts of COVID-19.
The vaccines, procured under the COVAX cost-share option, comply with World Bank’s Vaccine Approval Criteria for financing and are certified as safe and effective for children as young as 12 years of age by the European Medicines Agency and the UK’s Medicines and Healthcare Products Regulatory Agency.
“Nepal was the second country globally to finalize procurement of vaccines through the COVAX cost-share scheme. The supply of Moderna vaccines is timely for Nepal, as we expand our vaccine coverage to adolescents 12-17 years of age,” said Mr. Birodh Khatiwada, Honorable Minister of Health and Population. “The Government is committed to vaccinating the entire eligible population by mid-April 2022 and the World Bank-financed Moderna vaccines will be instrumental in helping Nepal achieve its COVID-19 vaccination goal.”
In line with the recommendations of the National Immunization Advisory Committee and the National Immunization Committee, the Moderna vaccines will be administered to adolescent populations through immunization sites set up in schools, as well as sites to reach out-of-school adolescent populations…
 
 
World Organisation for Animal Health (OIE) [to 29 Jan 2022]
https://www.oie.int/en/media/news/
Press Releases, Statements
No new digest content identified.
 
 
WTO – World Trade Organisation [to 29 Jan 2022]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
Registrations open for WTO workshop on COVID-19 vaccines R&D, manufacturing and distribution
28 January 2022
With the objectives of supporting ongoing discussions and improving understanding of the practical aspects of COVID-19 vaccine research and development (R&D), manufacturing and distribution, the WTO Secretariat is organizing a technical workshop on 11 February 2022.

WTO Members discuss way forward in dedicated meeting on WTO pandemic response
27 January 2022
WTO members met on 27 January to discuss the WTO response to the COVID-19 pandemic. The informal meeting convened by the Chair of the General Council, Ambassador Dacio Castillo of Honduras, looked at issues related to cross-border trade flows and the proposal to waive certain intellectual property protections related to COVID-19 countermeasures. Director-General Ngozi Okonjo-Iweala called on members to move swiftly to try and reach a comprehensive outcome by the end of February.
[See Perspectives above for detail]

 

::::::
 
 
ARM [Alliance for Regenerative Medicine] [to 29 Jan 2022]
https://alliancerm.org/press-releases/
Selected Press Releases
No new digest content identified.
 
 
BIO [to 29 Jan 2022]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network [to 29 Jan 2022]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.
 
 
ICBA – International Council of Biotechnology Associations [to 29 Jan 2022]
https://internationalbiotech.org/news/
News
No new digest content identified.
 
 
IFPMA [to 29 Jan 2022]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
IFPMA, BIO and DCVMN Statement on Influenza Preparedness for WHO EB150 agenda item 15.4
28 January 2022
Industry welcomes the progress made so far in influenza preparedness, although we wish to call out 3 key policy areas where much work still needs to be done: 1) improving seasonal influenza vaccine coverage, 2) addressing the increasing challenges and barriers being posed by national ABS legislation in accessing pathogen samples, and 3) in finally defining how to declare an influenza pandemic – still an open item at WHO more than 10 years after the last pandemic. It is also essential to ensure that the expansion of GISRS to include SARS-CoV-2 and RSV does not undermine the excellent work being done so far for influenza surveillance.
We are concerned to see that generic antiviral manufacturers are signing voluntary SMTA-2s under the PIP Framework, when for IFPMA, BIO and DCVMN members those are mandatory for access to pandemic influenza virus samples. We ask WHO to clarify why those are not mandatory agreements as well, as this could create a major gap in access to antivirals in the event of a pandemic as the majority of global supply of antivirals is now with generic manufacturers.
Finally, we reiterate our concerns about national ABS legislation continuing to hinder access to physical samples of influenza viruses. This is no longer just ‘a risk’, it is a reality: in 2021 one manufacturer lost 40% of their vaccine production capacity due to the inability to use the best strain for manufacturing, as there was no legal clarity regarding the use of that strain from a certain country. Measures such as potentially expanding the PIP Framework, a non-legally binding instrument, would simply not address such issues, and could weaken the Framework by forcing its reopening for negotiation.

IFPMA and GSCF Statement on Non-Communicable Diseases for WHO EB150 agenda item 7
24 January 2022

IFPMA Statement on Pandemic Preparedness and Response for EB150 agenda item 15.1
24 January 2022

 
 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.
 
 
International Alliance of Patients’ Organizations – IAPO [to 29 Jan 2022]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
No new digest content identified.
 
 
PhRMA [to 29 Jan 2022]
http://www.phrma.org/
Latest News [Selected]
No new digest content identified.

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Should Feedback of Individual Results be Integrated into the Consent Process in African Genomics? Participants’ Views from an HIV-TB Genomics Research Project in Botswana

AJOB Empirical Bioethics
Volume 13, 2022 Issue 1
https://www.tandfonline.com/toc/uabr21/current

 

Article
Should Feedback of Individual Results be Integrated into the Consent Process in African Genomics? Participants’ Views from an HIV-TB Genomics Research Project in Botswana
Dimpho Ralefala, Mary Kasule, Ambroise Wonkam, Mogomotsi Matshaba & Jantina de Vries
Pages: 48-56
Published online: 01 Jul 2021

Inequity Along the Medical/Dental Divide

AMA Journal of Ethics
Volume 24, Number 1: E1-105 Jan 2022
https://journalofethics.ama-assn.org/issue/inequity-along-medicaldental-divide

 

Inequity Along the Medical/Dental Divide
Dental and medical health systems in the United States have evolved as fully separate entities. This division exacerbates health inequity, since patients’ poor oral health affects their general health. The professionally entrenched view that what’s in patients’ mouths is somehow isolated from what’s going on in the rest of their bodies is one all clinicians need to resist, since this view can be a source of harm, particularly among vulnerable patients and communities. Practical and ethical strategies for better aligning medical and dental goals of care are considered in this issue.

Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 29 Jan 2022)

 

Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France
Vaccination is expected to change the epidemiology and management of SARS-CoV-2 epidemics.
Authors: Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Vittoria Colizza, Yazdan Yazdanpanah, Arnaud Fontanet, Daniel Benamouzig and Simon Cauchemez
Citation: BMC Medicine 2022 20:33
Content type: Research article
Published on: 26 January 2022

Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 29 Jan 2022)

 

Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey
Suboptimal human papillomavirus (HPV) vaccination rates persist among adolescents in the United States (U.S.). New Jersey (NJ), among the top, most racially/ethnically diverse states in the U.S., had among the…
Authors: Bianca Anuforo, Jennifer K. McGee-Avila, Lindsey Toler, Baichen Xu, Racquel E. Kohler, Sharon Manne and Jennifer Tsui
Citation: BMC Public Health 2022 22:195
Content type: Research article
Published on: 29 January 2022

Socioeconomic inequalities in non- coverage of full vaccination among children in Bangladesh: a comparative study of Demographic and Health Surveys, 2007 and 2017–18

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 29 Jan 2022)

 

Socioeconomic inequalities in non- coverage of full vaccination among children in Bangladesh: a comparative study of Demographic and Health Surveys, 2007 and 2017–18
Vaccination is considered as a powerful and cost-effective weapon against many communicable diseases. An increase in full vaccination among the most vulnerable populations in Bangladesh was observed in the la…
Authors: Shobhit Srivastava, T. Muhammad, Rashmi Rashmi and Pradeep Kumar

Replacing vaccine paper package inserts: a multi-country questionnaire study on the acceptability of an electronic replacement in different target groups

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 29 Jan 2022)

 

Replacing vaccine paper package inserts: a multi-country questionnaire study on the acceptability of an electronic replacement in different target groups
In the European Union it is mandatory to include paper package leaflets (PPL) with all medicines, including vaccines, to inform the recipient. However, it is difficult to meet the necessity for localized PPLs …
Authors: Martina Bamberger, Hans De Loof, Charlotte Marstboom, Stéphanie Oury, Paolo Bonanni, Odile Launay, Mira Kojouharova and Pierre Van Damme
Citation: BMC Public Health 2022 22:156
Content type: Research article
Published on: 24 January 2022

The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 29 Jan 2022]

 

The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings
Authors: Zamathombeni Duma, Anil A. Chuturgoon, Veron Ramsuran, Vinodh Edward, Pragalathan Naidoo, Miranda N. Mpaka-Mbatha, Khethiwe N. Bhengu, Nomzamo Nembe, Roxanne Pillay, Ravesh Singh and Zilungile L. Mkhize-Kwitshana
Content type: Review
22 January 2022

Localisation and local humanitarian action

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/localisation-and-local-humanitarian-action/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

Article
Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis
Vaibhav Kumar, Venetia Aranha, Rajni Rajgarhia, Abhishek Royal & Kedar Mehta
Pages: 3843-3849
Published online: 15 Jul 2021

Tracking the progress in COVID-19 and vaccine safety research – a comprehensive bibliometric analysis of publications indexed in Scopus database

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

Article
Tracking the progress in COVID-19 and vaccine safety research – a comprehensive bibliometric analysis of publications indexed in Scopus database
Tosin Yinka Akintunde, Shaojun Chen, Taha Hussein Musa, Felix Oluseyi Amoo, Adekunle Adedeji, Elhakim Ibrahim, Angwi Enow Tassang, Idriss Hussein Musa & Hassan Hussein Musa
Pages: 3887-3897
Published online: 06 Oct 2021

Intention to get COVID-19 vaccines: Exploring the role of attitudes, subjective norms, perceived behavioral control, belief in COVID-19 misinformation, and vaccine confidence in Northern India

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

Article
Intention to get COVID-19 vaccines: Exploring the role of attitudes, subjective norms, perceived behavioral control, belief in COVID-19 misinformation, and vaccine confidence in Northern India
Fatema Husain, Md Ghazi Shahnawaz, Neda Haseeb Khan, Heena Parveen & Krishna Savani
Pages: 3941-3953
Published online: 21 Sep 2021

Willingness and influential factors of parents of 3-6-year-old children to vaccinate their children with the COVID-19 vaccine in China

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

Article
Willingness and influential factors of parents of 3-6-year-old children to vaccinate their children with the COVID-19 vaccine in China
Xiao Wan, Haitao Huang, Jia Shang, Zhenxing Xie, Ruiying Jia, Guangli Lu & Chaoran Chen
Pages: 3969-3974
Published online: 03 Aug 2021

COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

article commentary
COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns
Khan Sharun, Ruchi Tiwari, Kuldeep Dhama, Ali A. Rabaan & Saad Alhumaid
Pages: 4108-4111
Published online: 22 Jul 2021

Fake COVID-19 vaccines: scams hampering the vaccination drive in India and possibly other countries

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

Article
Fake COVID-19 vaccines: scams hampering the vaccination drive in India and possibly other countries
Om Prakash Choudhary, Priyanka, Indraj Singh, Teroj A. Mohammed & Alfonso J. Rodriguez-Morales
Pages: 4117-4118
Published online: 06 Aug 2021

Mapping the global research output on Ebola vaccine from research indexed in web of science and scopus: a comprehensive bibliometric analysis

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

Article
Mapping the global research output on Ebola vaccine from research indexed in web of science and scopus: a comprehensive bibliometric analysis
Tosin Yinka Akintunde, Taha Hussein Musa, Hassan Hussein Musa, Shaojun Chen, Elhakim Ibrahim, Sayibu Muhideen & Joseph Kawuki
Pages: 4246-4258
Published online: 16 Jul 2021

Understanding the determinants of vaccine hesitancy and vaccine confidence among adolescents: a systematic review

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 17, Issue 11, 2021
https://www.tandfonline.com/toc/khvi20/current

 

review article
Understanding the determinants of vaccine hesitancy and vaccine confidence among adolescents: a systematic review
Chiara Cadeddu, Carolina Castagna, Martina Sapienza, Teresa Eleonora Lanza, Rosaria Messina, Manuela Chiavarini, Walter Ricciardi & Chiara de Waure
Pages: 4470-4486
Published online: 02 Sep 2021

Feasibility, acceptability, and effectiveness of non-pharmaceutical interventions against infectious diseases among crisis-affected populations: a scoping review

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 29 Jan 2022]

 

Feasibility, acceptability, and effectiveness of non-pharmaceutical interventions against infectious diseases among crisis-affected populations: a scoping review
Non-pharmaceutical interventions (NPIs) are a crucial suite of measures to prevent and control infectious disease outbreaks. Despite being particularly important for crisis-affected populations and those livin…
Authors: Jonathan A. Polonsky, Sangeeta Bhatia, Keith Fraser, Arran Hamlet, Janetta Skarp, Isaac J. Stopard, Stéphane Hugonnet, Laurent Kaiser, Christian Lengeler, Karl Blanchet and Paul Spiegel
Citation: Infectious Diseases of Poverty 2022 11:14
Content type: Scoping Review
Published on: 28 January 2022

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

JAMA
January 25, 2022, Vol 327, No. 4, Pages 305-401
https://jamanetwork.com/journals/jama/currentissue

 

Original Investigation
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
Matthew E. Oster, MD, MPH; David K. Shay, MD, MPH; John R. Su, MD, PhD, MPH; et al.
free access has active quiz
JAMA. 2022;327(4):331-340. doi:10.1001/jama.2021.24110
This descriptive study compares the effect of mRNA-based COVID-19 vaccination with BNT162b2 (Pfizer-BioNTech) vs mRNA-1273 (Moderna) on the reported cases of myocarditis in the US after each vaccination dose.

Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel

JAMA
January 25, 2022, Vol 327, No. 4, Pages 305-401
https://jamanetwork.com/journals/jama/currentissue

 

Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
Avishay Spitzer, MD; Yoel Angel, MD, MBA; Or Marudi, MSc; et al.
free access has active quiz
JAMA. 2022;327(4):341-349. doi:10.1001/jama.2021.23641
This cohort study estimates the association of a BNT162b2 (Pfizer-BioNTech) vaccine booster dose with SARS-CoV-2 infections among health care workers in Israel previously vaccinated with a 2-dose series of BNT162b2.

Winter of Omicron—The Evolving COVID-19 Pandemic

JAMA
January 25, 2022, Vol 327, No. 4, Pages 305-401
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Winter of Omicron—The Evolving COVID-19 Pandemic
Carlos del Rio, MD; Saad B. Omer, MBBS, MPH, PhD; Preeti N. Malani, MD, MSJ
free access has multimedia has audio
JAMA. 2022;327(4):319-320. doi:10.1001/jama.2021.24315
This Viewpoint discusses the Omicron variant of SARS-CoV-2, including its likely origin, the importance of vaccination, the other tools available to combat a surge in COVID-19 cases, and the possibility of a “twindemic” with influenza.

Identifying COVID-19 and H1N1 vaccination hesitancy or refusal among health care providers across North America, the United Kingdom, Europe, and Australia: a scoping review protocol

JBI Evidence Synthesis
January 2022 – Volume 20 – Issue 1
https://journals.lww.com/jbisrir/Pages/currenttoc.aspx

 

SYSTEMATIC REVIEW PROTOCOLS
Identifying COVID-19 and H1N1 vaccination hesitancy or refusal among health care providers across North America, the United Kingdom, Europe, and Australia: a scoping review protocol
Gallant, Allyson J.; Steenbeek, Audrey; Curran, Janet A.
JBI Evidence Synthesis. 20(1):173-180, January 2022.

Parental experiences of caring for their preschool children after declining vaccines: a qualitative systematic review protocol

JBI Evidence Synthesis
January 2022 – Volume 20 – Issue 1
https://journals.lww.com/jbisrir/Pages/currenttoc.aspx

 

Parental experiences of caring for their preschool children after declining vaccines: a qualitative systematic review protocol
Huel, Christine; Harding, Jillian; MacKinnon, Karen; More
JBI Evidence Synthesis. 20(1):196-203, January 2022.

Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine

Journal of Infectious Diseases
Volume 225, Issue 1, 1 January 2022
https://academic.oup.com/jid/issue/225/1

 

MAJOR ARTICLES AND BRIEF REPORTS
Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine
Yaki Saciuk, Jennifer Kertes, Naama Shamir Stein, Anat Ekka Zohar
The Journal of Infectious Diseases, Volume 225, Issue 1, 1 January 2022, Pages 30–33, https://doi.org/10.1093/infdis/jiab556
Providing a third dose of BNT152b2 6 months after the first 2 doses evidenced a vaccine effectiveness against infection rate of 89%. The reduction in infection risk 2 months after the third-dose vaccination campaign reinforces the wisdom of its implementation.

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

The Lancet
Jan 29, 2022 Volume 399 Number 10323 p411-494, e2
https://www.thelancet.com/journals/lancet/issue/current

 

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Lulu Bravo, et al.

Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability

The Lancet
Jan 29, 2022 Volume 399 Number 10323 p411-494, e2
https://www.thelancet.com/journals/lancet/issue/current

 

Health Policy
Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability
Suerie Moon, PhD Jana Armstrong, MBA Brian Hutler, PhD Prof Ross Upshur, MD Rachel Katz, MA Caesar Atuire, PhD et al. Show all authors
Published:December 10, 2021
DOI: https://doi.org/10.1016/S0140-6736(21)02344-8
Summary
The Access to COVID-19 Tools Accelerator (ACT-A) is a multistakeholder initiative quickly constructed in the early months of the COVID-19 pandemic to respond to a catastrophic breakdown in global cooperation. ACT-A is now the largest international effort to achieve equitable access to COVID-19 health technologies, and its governance is a matter of broad public importance. We traced the evolution of ACT-A’s governance through publicly available documents and analysed it against three principles embedded in the founding mission statement of ACT-A: participation, transparency, and accountability. We found three challenges to realising these principles. First, the roles of the various organisations in ACT-A decision making are unclear, obscuring who might be accountable to whom and for what. Second, the absence of a clearly defined decision making body; ACT-A instead has multiple centres of legally binding decision making and uneven arrangements for information transparency, inhibiting meaningful participation. Third, the nearly indiscernible role of governments in ACT-A, raising key questions about political legitimacy and channels for public accountability. With global public health and billions in public funding at stake, short-term improvements to governance arrangements can and should now be made. Efforts to strengthen pandemic preparedness for the future require attention to ethical, legitimate arrangements for governance.

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Nature
Volume 601 Issue 7894, 27 January 2022
https://www.nature.com/nature/volumes/601/issues/7894

 

Article | 23 November 2021 | Open Access
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
A phase I open-label trial evaluating the immunogencity, reactogenicity and safety of a peptide-based SARS-CoV-2 vaccine candidate to induce SARS-CoV-2-specific T cell responses.
Jonas S. Heitmann, Tatjana Bilich, Juliane S. Walz

The past, present and future of Registered Reports

Nature Human Behaviour
Volume 6 Issue 1, January 2022
https://www.nature.com/nathumbehav/volumes/6/issues/1

 

Review Article | 15 November 2021
The past, present and future of Registered Reports
Registered Reports were introduced a decade ago as a means for improving the rigour and credibility of confirmatory research. Chambers and Tzavella overview the format’s past, its current status and future developments.
Christopher D. Chambers, Loukia Tzavella

The future of human behaviour research

Nature Human Behaviour
Volume 6 Issue 1, January 2022
https://www.nature.com/nathumbehav/volumes/6/issues/1

 

Feature | 27 January 2022
The future of human behaviour research
Human behaviour is complex and multifaceted, and is studied by a broad range of disciplines across the social and natural sciences. To mark our 5th anniversary, we asked leading scientists in some of the key disciplines that we cover to share their vision of the future of research in their disciplines. Our contributors underscore how important it is to broaden the scope of their disciplines to increase ecological validity and diversity of representation, in order to address pressing societal challenges that range from new technologies, modes of interaction and sociopolitical upheaval to disease, poverty, hunger, inequality and climate change. Taken together, these contributions highlight how achieving progress in each discipline will require incorporating insights and methods from others, breaking down disciplinary silos.
Janet M. Box-Steffensmeier, Jean Burgess, Claudia Wagner

Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever

Nature Medicine
Volume 28 Issue 1, January 2022
https://www.nature.com/nm/volumes/28/issues/1

 

News Feature | 14 January 2022
Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever
Medical discoveries have been shared at an unprecedented pace during the COVID-19 pandemic, but so have fraudulent studies, which has led to worries about scientific integrity.
Clare Watson

Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 29 Jan 2022)

 

Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries
Roy Rillera Marzo, Absar Ahmad, Md. Saiful Islam, Mohammad Yasir Essar, Petra Heidler, Isabel King, Arulmani Thiyagarajan, Kittisak Jermsittiparsert, Karnjana Songwathana, Delan Ameen Younus, Radwa Abdullah El-Abasiri, Burcu Kucuk Bicer, Nhat Tan Pham, Titik Respati, Susan Fitriyana, Erwin Martinez Faller, Aries Moralidad Baldonado, Md Arif Billah, Yadanar Aung, Shehu Muhammad Hassan, Muhammad Mujtaba Asad, Kareem Ahmed El-Fass, Sudip Bhattacharya, Sunil Shrestha, Nouran Ameen Elsayed Hamza, Pascal Friedmann, Michael Head, Yulan Lin, Siyan Yi
Research Article | published 28 Jan 2022 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0010103